VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GALT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GALTGalectin Therapeutics Inc.
$4.61$304M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksGALTQuarterly Financials

Galectin Therapeutics Inc. (GALT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Galectin Therapeutics Inc. (GALT) quarterly income statement — complete revenue, gross profit & net income history

GALT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit00000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses4.08M3.37M4.2M4.63M7.9M12.43M9.07M11.29M9.65M9.56M9.17M9M10.34M10.63M8.12M9.66M9.94M7.42M8.24M8.19M
OpEx % of Revenue--------------------
Selling, General & Admin1.85M1.43M1.59M1.36M1.41M1.32M1.47M1.48M1.59M1.33M1.43M1.63M1.54M1.63M1.52M1.59M1.88M1.57M1.63M1.74M
SG&A % of Revenue--------------------
Research & Development2.23M1.93M2.61M3.26M6.49M11.11M7.59M9.81M8.05M8.23M7.73M7.37M8.8M9.01M6.6M8.07M8.06M5.86M6.61M6.45M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-4.08M-3.37M-4.2M-4.63M-7.9M-12.43M-9.07M-11.29M-9.65M-9.56M-9.17M-9M-10.34M-10.63M-8.12M-9.66M-9.94M-7.42M-8.24M-8.19M
Operating Margin %--------------------
Operating Income Growth %48.37%72.92%53.7%59.04%18.15%-29.99%1.09%-25.41%6.71%10.08%-12.85%6.82%-4.1%-43.21%1.48%-17.93%-57.27%5.2%-39.12%-34.27%
EBITDA-4.07M-3.32M-6.36M-4.62M-7.89M-12.42M-9.06M-11.28M-9.64M-9.55M-9.16M-8.46M-10.31M-10.63M-8.12M-9.65M-9.93M-7.41M-8.23M-8.18M
EBITDA Margin %--------------------
EBITDA Growth %48.46%73.23%29.73%59.02%18.18%-30%1.1%-33.29%6.51%10.1%-12.85%12.34%-3.88%-43.31%1.45%-17.99%-57.36%5.23%-39.18%-34.28%
D&A (Non-Cash Add-back)12K41K02K10K10K9K9K9K9K8K032K8K7K7K10K11K10K10K
EBIT-4.08M-3.56M-6.36M-5.7M-7.89M-10.24M-9.73M-11.1M-10.44M-9.15M-9.59M-8.46M-11.07M-10.33M-8.33M-9.38M-9.71M-6.95M-8.41M-8.36M
Net Interest Income-1.95M-1.91M-1.78M-1.8M-1.71M-1.64M-1.4M-1.19M-972K-773K-773K-600K-416K-278K-251K-226K-226K-272K-110K-84K
Interest Income36K26K39K26K35K84K93K80K80K74K62K50K44K30K18K3K1K01K1K
Interest Expense1.99M1.94M1.82M1.83M1.74M1.73M1.49M1.27M1.05M847K835K650K460K308K269K229K227K272K111K85K
Other Income/Expense-969K-2.13M-3.99M-2.9M-1.73M461K-2.15M-1.08M-1.84M-436K-1.26M-111K-1.19M-1K-475K49K3K204K-276K-256K
Pretax Income-5.05M-5.5M-8.18M-7.52M-9.63M-11.97M-11.22M-12.37M-11.49M-10M-10.43M-9.11M-11.53M-10.63M-8.6M-9.61M-9.93M-7.22M-8.52M-8.45M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-5.05M-5.5M-8.18M-7.52M-9.63M-11.97M-11.22M-12.37M-11.49M-10M-10.43M-9.11M-11.53M-10.63M-8.6M-9.61M-9.93M-7.22M-8.52M-8.45M
Net Margin %--------------------
Net Income Growth %47.61%54.04%27.06%39.2%16.17%-19.71%-7.59%-35.74%0.33%5.99%-21.3%5.19%-16.06%-47.26%-0.9%-13.78%-56.71%8.04%-43.36%-38.19%
Net Income (Continuing)-5.05M-5.5M-8.18M-7.52M-9.63M-11.97M-11.22M-12.37M-11.49M-10M-10.43M-9.11M-11.53M-10.63M-8.6M-9.61M-9.93M-7.22M-8.52M-8.45M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.08-0.08-0.13-0.12-0.15-0.19-0.18-0.20-0.19-0.16-0.24-0.15-0.19-0.51-0.14-0.16-0.17-0.12-0.14-0.15
EPS Growth %48.67%57.89%27.78%40%21.05%-18.75%25%-33.33%0%68.63%-71.43%6.25%-11.76%-325%0%-6.67%-54.55%14.29%-40%-36.36%
EPS (Basic)-0.08-0.08-0.13-0.12-0.15-0.19-0.18-0.20-0.19-0.16-0.24-0.15-0.19-0.51-0.14-0.16-0.17-0.12-0.14-0.15
Diluted Shares Outstanding65.78M63.9M64.2M63.45M63.2M62.74M62.28M62.23M61.98M60.16M59.7M59.58M59.48M59.43M59.4M59.39M59.35M58.53M59.29M58.31M
Basic Shares Outstanding65.78M63.9M64.2M63.45M63.2M62.74M62.28M62.23M61.98M60.16M59.7M59.58M59.48M59.43M59.4M59.39M59.35M58.53M59.29M58.31M
Dividend Payout Ratio--------------------